Quick Takeaways
- Laura Shawver has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,587,466.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Laura Shawver
- Location
- Cary, NC
- Summary
- The estimated net worth of Laura Shawver is at least $2,587,466 dollars as of 27 Jun 2025. Laura Shawver is the Director of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $2.59M.
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Laura Shawver and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: ARS Pharmaceuticals, Inc. ($2,587,466).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Laura Shawver
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Director | $2,587,466 | 25 Jun 2025 | ||
| NKTX | Nkarta, Inc. | Director | 08 Jun 2022 | |||
| RLAY | Relay Therapeutics, Inc. | Director | 03 Jun 2024 |
Insider Transactions Reported by Laura Shawver:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.